Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2024 / Jul / Also in the News… (1)
Research & Innovations Retina Professional Development Health Economics and Policy

Also in the News…

From new Vabysmo approvals to RP treatment developments, these are the news stories and studies that caught our attention this week…

By Alun Evans 7/12/2024 3 min read

Share

Credit: Bausch + Lomb

Vabysmo pre-filled syringe. The FDA has approved Roche’s Vabysmo 6.0 mg single-dose pre-filled syringe (PFS) for three leading causes of vision loss. The PFS delivers the same medicine as is currently available in vial form, but now in a ready-to-use format. Link

Dry Eye survey. Bausch + Lomb have released the results from their inaugural State of Dry Eye survey, which was designed to understand the experiences of American adults suffering from dry eye disease. Link

Breakthrough RP treatment. Case Western Reserve University has received a $1.5 million three-year grant from the Foundation for Fighting Blindness to help in their work towards developing an oral drug treatment for retinitis pigmentosa (RP). Link

GAN for DME. Scientists from the Doheny Eye Institute, California, used generative adversarial network (GAN) models to generate gradable optical coherence tomography (OCT) images. The team found that the GAN-generated models showed positive predictive values and specificity, indicating that this modality could help identify potential non responders of long-term diabetic macular edema (DME) treatment. Link

Remote imaging prospects. Researchers at Bascom Palmer Eye Institute, Miami, have compared a new remote-controlled and portable slit lamp prototype’s imaging capabilities with the Haag-Streit AG and the BX 900 slit lamp biomicroscope, finding the new device’s diagnostic accuracy comparable. The prototype’s remote functionality and accessibility could help broaden access to eye care at primary care level and further enhance the future of teleophthalmology, the study reports. Link

VEGF-A elevation. Researchers from the University of Athens, Greece, have discovered that VEGF-A levels are substantially elevated in the aqueous humor of primary open angle glaucoma (POAG) eyes. The findings indicate that various retinal cells might be responsible for this elevation, aligning with existing literature that also reports increased levels of VEGF-A in POAG patients. Link

SLT efficacy. Post-hoc analysis published in Ophthalmology finds that selective laser trabeculoplasty (SLT) performs better for a higher baseline intraocular pressure (IOP) as a first-line treatment for open angle glaucoma and ocular hypertension than typical hypotensive medication. Link

About the Author(s)

Alun Evans

More Articles by Alun Evans

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: